<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { padding-top: 0 ; padding-bottom: 0 }
--></style><title>"Essentials of a Sucessful Biotech Startup"
is on March 8</title></head><body>
<blockquote type="cite" cite>
<blockquote type="cite" cite><br>
<font color="#FF0000"><i><b>Ever wanted to know to how to start your
own company? Want to know the pitfalls before you
begin? <br>
</b></i></font>Come on<font color="#0000FF"><b> March 8</b></font> to
hear<font color="#0000FF"><b> Alain Hanover</b></font>, Senior
Managing Director and CEO of Navigator Technology Ventures talk about
his experiences and hear his advice on what to do and not to do when
beginning your own biotech company. <br>
<br>
As always, cookies, coffee and soda will be provided before the
lecture.<br>
<br>
******************************************************************<br>
<font color="#0000FF"><b>March 8, 2006 (Wednesday).<br>
</b></font>Lecture at 7:00 pm.<br>
Refreshments at 6:30 pm.<br>
Room 66-110.<br>
------------------------------------------------<br>
<br>
<font size="+2" color="#FF0000"><b>Essentials of a Successful Biotech
Startup<br>
<br>
</b></font><font size="+1" color="#0000FF"><b>Alain Hanover<br>
</b></font>Senior Managing Director and CEO<br>
Navigator Technology Ventures<br>
Cambridge, MA<br>
<br>
-----------------------------------------------<br>
<font color="#0000FF">About the Lecture:<br>
</font>Navigator Technology Ventures is an early-stage venture fund
that specializes in bringing electronics-based technologies to market,
from Technical Software to Medical Devices. One third of its
portfolio are Biotech companies. For these investments, NTV
seeks out companies that will best mitigate the 7 major risks they
face: people risk, market risk, development risk, financial risk,
regulatory risk, reimbursement risk, and acceptance risk. Mr.
Hanover will discuss these issues and elaborate on how some start-ups
address these various risk factors in order to make themselves more
attractive to investors and increase their chance of success.<br>
<br>
<font color="#0000FF">About the Speaker:<br>
</font>Prior to becoming a Venture Capitalist, Hanover was co-Founder,
President and CEO of InCert Software Corporation between 1997 and
2000. He raised $9M in venture funding for InCert, and was responsible
for its strategic direction and the launching of 2 products. Incert
was sold to Veritas. Before joining InCert, Hanover was founder, CEO,
President and Chairman of ViewLogic, a leading electronic design
automation software company from 1984 to 1997. Hanover led ViewLogic
from its inception to sales of more than $150M and 700 employees,
prior to its sale to Synopsys in 1997. He raised $16.5M in
venture capital and took it public in 1991. In 1993, he was
named Entrepreneur of the Year. Prior to Viewlogic, Hanover held
senior executive and engineering positions at Digital Equipment
Corporation, Dymo, Xylogics and MIT Lincoln Laboratory.<br>
<br>
************************************************<br>
<br>
Please forward to those who might be interested.<br>
<br>
<br>
<br>
<br>
<br>
co-sponsored by the IEEE EMBS, Boston Chapter.</blockquote>
</blockquote>
<div><br></div>
</body>
</html>